Seong-Chul Kim
Director/Board Member at KPS CORPORATION
Net worth: 3 M $ as of 29/04/2024
Seong-Chul Kim active positions
| Companies | Position | Start | End |
|---|---|---|---|
| KPS CORPORATION | Director/Board Member | - | - |
Career history of Seong-Chul Kim
Former positions of Seong-Chul Kim
| Companies | Position | Start | End |
|---|---|---|---|
LSK Investment Co. Ltd.
 LSK Investment Co. Ltd. Investment ManagersFinance LSK Investment Co. Ltd. (LSK Investment), a private equity & venture capital subsidiary of HLB Life Science Co Ltd., was founded in 2016. The firm is headquartered in Seoul, South Korea. | Chief Executive Officer | 10/04/2016 | 30/12/2018 |
Elevar Therapeutics, Inc.
 Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Director/Board Member | - | - |
| Chief Executive Officer | - | - | |
| Founder | 31/12/2004 | - | |
| President | 31/12/2004 | - | |
| HLB CO., LTD. | Director/Board Member | - | - |
| Corporate Officer/Principal | - | - |
Statistics
International
| South Korea | 4 |
| United States | 2 |
Operational
| Director/Board Member | 3 |
| Chief Executive Officer | 2 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 3 |
| Finance | 2 |
| Electronic Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| HLB CO., LTD. | Health Technology |
| KPS CORPORATION | Electronic Technology |
| Private companies | 2 |
|---|---|
Elevar Therapeutics, Inc.
Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Health Technology |
LSK Investment Co. Ltd.
LSK Investment Co. Ltd. Investment ManagersFinance LSK Investment Co. Ltd. (LSK Investment), a private equity & venture capital subsidiary of HLB Life Science Co Ltd., was founded in 2016. The firm is headquartered in Seoul, South Korea. | Finance |
- Stock Market
- Insiders
- Seong-Chul Kim
- Experience
